Botanical species · safety record

Uncaria tomentosa

The EFSA Compendium of Botanicals holds 4 constituent measurements and 3 adverse-effect records for Uncaria tomentosa. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Uncaria tomentosa (Willd. ex Schult.) DC.

4Constituent measurements
3Safety records
5Cited sources
190Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 190 licensed products naming Uncaria tomentosa as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Extract Type TBA

Source material stated

  • Aged bark
  • Bark
  • Bark (powder)
  • Bark and roots
  • Bark extract
  • Branch
  • Branch bark
  • Herb

What the records describe

Constituents measured

  • Indole alkaloids3
  • Tannins1

Plant parts

  • Bark4
  • Unspecified3

Preparations

  • Solvent extraction4

Effect types

  • Teratogenic2
  • Nephrotoxicity1

Target tissues

  • Muscle, skeletal2
  • Urogenital: kidneys1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Indole alkaloidsBarkSolvent extractionGC-MSResolve DOI
Indole alkaloidsBarkSolvent extractionHPLC with standard detection methodsResolve DOI
Indole alkaloidsBarkSolvent extractionHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
TanninsBarkSolvent extractionHPLC with standard detection methodsResolve DOI

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
NephrotoxicityUrogenital: kidneysUnspecifiedHuman (as organism)Case reportResolve DOI
TeratogenicMuscle, skeletalUnspecifiedHouse mouse (as animal)Reproduction toxicityNo resolvable identifier
TeratogenicMuscle, skeletalUnspecifiedHouse mouse (as animal)Reproduction toxicityNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Garcia Gimenez, Dolores., Garcia Prado, Elena., Saenz Rodriguez, Teresa., Fernandez Arche, Angeles., De la Puerta, Rocio. Cytotoxic Effect of the Pentacyclic Oxindole Alkaloid Mitraphylline Isolated from Uncaria tomentosa Bark on Human Ewing's Sarcoma and Breast Cancer Cell Lines . Planta medica, 2010, vol. 76, no. 2, p. 133-136. DOI
  2. Kuras, Mieczyslaw., Pilarski, Radoslaw., Nowakowska, Julita., Zobel, Alicja., Brzost, Krzysztof., Antosiewicz, Justyna., Gulewicz, Krzysztof. Effect of Alkaloid-Free and Alkaloid-Rich preparations from Uncaria tomentosa bark on mitotic activity and chromosome morphology evaluated by Allium Test. JOURNAL OF ETHNOPHARMACOLOGY, 2009, vol. 121, no. 1, p. 140-147. DOI
  3. Pilarski, Radoslaw., Filip, Beata., Wietrzyk, Joanna., Kuras, Mieczyslaw., Gulewicz, Krzysztof. Anticancer activity of the Uncaria tomentosa (Willd.) DC. preparations with different oxindole alkaloid composition . Phytomedicine, 2010, vol. 17, no. 14, p. 1133-1139. DOI
  4. Steenkamp, V., Stewart, M.J. Nephrotoxicity associated with exposure to plant toxins, with particular reference to Africa. Therapeutic drug monitoring, 2005, vol. 27, no. 3, p. 270-277. DOI
  5. Iziga, R., Gutierrez-Pajares, J., Pino, J. In vivo effect of Uncaria tomentosa (Willd.) D C. (Rubiaceae) Cat's claw on the 72 h.p.c. preimplantation mouse embryo development . Boletin de la sociedad de biologia de concepcion, 1998, vol. 69, no. 0, p. 141-145.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue